Helen Collins
2017
In 2017, Helen Collins earned a total compensation of $2.7M as Senior Vice President and Chief Medical Officer at Five Prime Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $170,050 |
|---|---|
| Option Awards | $801,299 |
| Salary | $400,208 |
| Stock Awards | $1,371,737 |
| Other | $6,000 |
| Total | $2,749,294 |
Collins received $1.4M in stock awards, accounting for 50% of the total pay in 2017.
Collins also received $170.1K in non-equity incentive plan, $801.3K in option awards, $400.2K in salary and $6K in other compensation.
Rankings
In 2017, Helen Collins' compensation ranked 3,995th out of 14,666 executives tracked by ExecPay. In other words, Collins earned more than 72.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,995 out of 14,666 | 73rd |
Division Manufacturing | 1,401 out of 5,768 | 76th |
Major group Chemicals And Allied Products | 403 out of 2,074 | 81st |
Industry group Drugs | 312 out of 1,730 | 82nd |
Industry Pharmaceutical Preparations | 249 out of 1,329 | 81st |
Source: SEC filing on March 30, 2018.
Collins' colleagues
We found four more compensation records of executives who worked with Helen Collins at Five Prime Therapeutics in 2017.